Not legal advice. Methodology and industry baselines only. Counsel must verify licensing before category change.

Kraken Kratom — Benchmark Brief

Type: Kratom powder, extract, and tablet manufacturer
Location: Portland, OR
Sources: krakenkratom.com/lab-testing, AKA GMP announcements


Public manufacturing claims

  • First AKA GMP Qualified Vendor (2019); renewed consecutive years
  • Dual-lab testing — two ISO 17025 labs per batch (failsafe)
  • Environmental pathogen monitoring — facility surface testing
  • Milling and blending — uniform composite for accurate lab sampling
  • Enhanced supplier screening post-2018 voluntary recall (Salmonella)
  • Test panel: alkaloids, heavy metals (AOAC 2013.06), micro (APC, Y/M, coliforms, E. coli, Salmonella AOAC-RI)

Inferred equipment / process chain

Stage Inference
Receiving / quarantine Hold until lab release; strict supplier vetting
Milling Coarse + fine grind for powder SKUs
Blending Composite blending for representative aliquots
Extract line Proprietary UEI extraction for tablet/concentrate SKUs
Sanitation Documented environmental monitoring program
Packaging Batch-coded; GMP-compliant pack room
QA Multi-lab COA gate; quarantine of suspect lots

Overlap with cannabis flour / extraction paths

Asset Fit
Dry milling train High
Blending High
Extraction (UEI) Maps to cannabis ethanol/CO2 for extract SKUs
Quarantine warehousing High — same physical pattern as cannabis intake
Dual-lab QA Process pattern — cannabis labs often use single lab; kratom category favors redundant testing

Black Rock outreach hook

Kraken's post-recall QA escalation is a credible case study for conversion targets nervous about microbial risk on import material. Oregon regulatory context differs from KCPA states — use for process benchmark, not jurisdiction template.


Compliance note

Oregon kratom rules evolving. Kraken operates as dietary supplement manufacturer posture. Conversion targets in other states must not assume OR licensing path transfers.